Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders

Details for Australian Patent Application No. 2009256157 (hide)

Owner Synergy Pharmaceuticals Inc.

Inventors Shailubhai, Kunwar; Jacob, Gray S.

Agent Cullens

Pub. Number AU-A-2009256157

PCT Pub. Number WO2009/149279

Priority 61/058,892 04.06.08 US

Filing date 4 June 2009

Wipo publication date 10 December 2009

International Classifications

C07K 7/08 (2006.01) Peptides having 5 to 20 amino acids in a fully defined sequence

A61K 38/04 (2006.01) Medicinal preparations containing peptides - Peptides having up to 20 amino acids in a fully defined sequence

A61P 1/04 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

20 January 2011 Amendment Made

  The nature of the amendment is: Amend co-inventor; Jacob, Gray S. to Jacob, Gary S.

20 January 2011 PCT application entered the National Phase

  PCT publication WO2009/149279 Priority application(s): WO2009/149279

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009256162-Heat and moisture exchange unit with resistance indicator

2009256156-Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders